Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Low androgen levels reduce nitric oxide production in rat penile cells.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

Platelet-rich plasma-derived exosomes can help regrow hair by activating a specific signaling pathway.

Androgens reduce hair growth by affecting cell differentiation and blood vessel formation.

AH-001 could be a safer and more effective treatment for hair loss.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

A new treatment for hair loss shows promise with fewer side effects.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

The method effectively measures drug impact on DHT levels in prostate treatments.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Laser therapy and hair growth factors significantly improve hair density in male baldness.

A new method accurately measures nine specific hormones in human blood.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.